NasdaqGM - Nasdaq Real Time Price USD

Cronos Group Inc. (CRON)

Compare
2.0200 -0.0100 (-0.49%)
At close: 4:00:01 PM EST
1.9900 -0.03 (-1.49%)
After hours: 4:29:48 PM EST
Loading Chart for CRON
DELL
  • Previous Close 2.0300
  • Open 2.0300
  • Bid 1.9900 x 600
  • Ask 2.0400 x 600
  • Day's Range 1.9940 - 2.0566
  • 52 Week Range 1.8600 - 3.1400
  • Volume 1,559,303
  • Avg. Volume 1,178,051
  • Market Cap (intraday) 772.236M
  • Beta (5Y Monthly) 1.01
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1200
  • Earnings Date Feb 26, 2025 - Mar 3, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.96

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

www.thecronosgroup.com

356

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRON

View More

Performance Overview: CRON

Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRON
3.59%
S&P/TSX Composite index
1.26%

1-Year Return

CRON
7.34%
S&P/TSX Composite index
19.07%

3-Year Return

CRON
46.98%
S&P/TSX Composite index
18.31%

5-Year Return

CRON
70.25%
S&P/TSX Composite index
45.74%

Compare To: CRON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRON

View More

Valuation Measures

As of 1/6/2025
  • Market Cap

    765.01M

  • Enterprise Value

    -95.17M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.97

  • Price/Book (mrq)

    0.72

  • Enterprise Value/Revenue

    0.02

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -56.43%

  • Return on Assets (ttm)

    -3.73%

  • Return on Equity (ttm)

    -5.29%

  • Revenue (ttm)

    101.78M

  • Net Income Avi to Common (ttm)

    -57.37M

  • Diluted EPS (ttm)

    -0.1200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    848.19M

  • Total Debt/Equity (mrq)

    0.19%

  • Levered Free Cash Flow (ttm)

    -30.52M

Research Analysis: CRON

View More

People Also Watch